Want to see IN:LINCOLN full AI Analyst Report?

Lincoln Pharmaceuticals Ltd (LINCOLN) Financial Statements

1 Followers

Lincoln Pharmaceuticals Ltd Financial Overview

Lincoln Pharmaceuticals Ltd's market cap is currently ₹11.66B. The company's EPS TTM is ₹48.16; its P/E ratio is 12.04; and it has a dividend yield of 0.31%. Lincoln Pharmaceuticals Ltd is scheduled to report earnings on August 13, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 6.71B	₹ 6.23B	₹ 5.81B	₹ 5.05B	₹ 4.68B
Gross Profit	₹ 2.20B	₹ 3.32B	₹ 2.97B	₹ 2.59B	₹ 2.46B
Operating Income	₹ 831.84M	₹ 885.94M	₹ 832.22M	₹ 779.91M	₹ 1.65B
EBITDA	₹ 1.31B	₹ 1.24B	₹ 1.34B	₹ 1.12B	₹ 1.05B
Net Income	₹ 878.94M	₹ 823.46M	₹ 933.05M	₹ 728.99M	₹ 693.55M
Balance Sheet
Cash & Short-Term Investments	₹ 2.41B	₹ 1.96B	₹ 1.52B	₹ 1.14B	₹ 1.15B
Total Assets	₹ 8.90B	₹ 7.97B	₹ 7.00B	₹ 5.87B	₹ 5.34B
Total Debt	₹ 44.22M	₹ 0.00	₹ 10.67M	₹ 19.97M	₹ 20.44M
Net Debt	₹ -282.36M	₹ -134.14M	₹ -46.80M	₹ -30.55M	₹ -48.90M
Total Liabilities	₹ 1.33B	₹ 1.25B	₹ 1.07B	₹ 849.46M	₹ 1.01B
Stockholders' Equity	₹ 7.58B	₹ 6.72B	₹ 5.93B	₹ 5.02B	₹ 4.33B
Cash Flow
Free Cash Flow	₹ 815.07M	₹ 737.71M	₹ 237.41M	₹ 249.80M	₹ 306.07M
Operating Cash Flow	₹ 1.07B	₹ 930.15M	₹ 632.17M	₹ 392.62M	₹ 761.32M
Investing Cash Flow	₹ -996.37M	₹ -789.47M	₹ -573.42M	₹ -366.43M	₹ -780.80M
Financing Cash Flow	₹ 8.16M	₹ -64.02M	₹ -51.80M	₹ -45.01M	₹ -25.56M

Currency in INR

Lincoln Pharmaceuticals Ltd Earnings and Revenue History

Income Statement >

Lincoln Pharmaceuticals Ltd Debt to Assets

Balance Sheet >

Lincoln Pharmaceuticals Ltd Cash Flow

Cash Flow >

Lincoln Pharmaceuticals Ltd Forecast EPS vs Actual EPS

Earnings >